-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Notice of the Center for Drug Review of the State Food and Drug Administration on the issuance of the "Technical Guidelines for the Research of Prescription Drugs of the Same Name (Trial)" (No.
48 of 2022)
48 of 2022)
Release date: 20221227
Under the deployment of the State Medical Products Administration, the Center for Drug Review organized and formulated the Technical Guidelines for the Research of Prescription Drugs of the Same Name (Trial) (see Annex).
In accordance with the requirements of the Notice of the General Department of the State Food and Drug Administration on the Procedures for Issuing Technical Guidelines for Drugs (Drug Administration [2020] No.
9), after the review and consent of the State Medical Products Administration, it is hereby issued and will come into force
on the date of promulgation.
Notice is hereby given
.
Annex: Technical Guidelines for the Study of Prescription Drugs of the Same Name (Trial)
Drug Review Center, State Food and Drug Administration
December 26, 2022